Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |